In 2021, vaccine giant Merca East opened its year with a cold splash of cold water on the development of a "crazy" new crown vaccine. January 25th, Mercedon will stop developing two candidate vaccines V590 and V591 for SARS-CoV-2/COVID-19.
Artificial sweeteners may not be a good partner for diabetics
Time of Update: 2021-02-15
, many people choose to replace sucrose and glucose with artificial sweeteners, whether to control calorie intake or worry about raising blood sugar. But the results of this study may allow people to reassess the effects of artificial
The most stringent VOC emission standards in July to implement wood coating "oil-to-water
Time of Update: 2021-01-27
not be underestimated, and the limits of pollutant emissions have reached the international advanced level. The standard stipulates that from now until December 31, 2016, the limit of the volatile organic matter content limit of coatings in ready
Nanjing Jianyou, Beijing Ted "Benzene Shun Aquku ammonium injection" will soon be approved for the market
Time of Update: 2021-01-05
, 20mg/10ml. , Nanjing Jianyou developed a total of 3 specifications of benzene shun aquku ammonium injection, including 10 mg/5 mL, 20 mg/10 mL, 200 mg/20 mL, all approved by the FDA in April 2019. then transferred to the domestic declaration
The bisceptoin pharmaceutical industry passed a consistent evaluation of molymin capsules
Time of Update: 2020-11-14
pharmaceutical company disclosed on September 1, 2020 that it had obtained a drug registration certificate for the thymosamine capsule (100mg) (as if it had passed a consistency evaluation).
The second batch of national collection completed 130% "oral sugar-lowering brother" was popular
Time of Update: 2020-10-26
The quantity was 163.8066 million tablets/branch/bag, and according to the drug statistics, the highest was 67.034 million tablets of Akapo sugar 50mg, and the lowest was 0.83 million tablets of Anlitan 5mg. Akapo sugar in Jiangxi winning
The second batch of national collection completed 130% of the "oral sugar-lowering brother" popular
Time of Update: 2020-10-10
the same product regulations is 86.36%; Achimycin 0.25g (winning enterprise Suzhou second leaf pharmaceutical), ometantan 20mg (winning enterprise Dongsian medicine), Solina new 5mg (winning enterprise Haizheng Pharmaceuticals) and Klinmycin 0.15g
NEJM: Egle Net does not increase cardiovascular risk in people with type 2 diabetes with atherosclerosis cardiovascular disease
Time of Update: 2020-10-05
Of the 5,499 patients in the Egle net group, 444 (8.1%) died of cardiovascular disease or were hospitalized for heart failure, compared with 250 (9.1% with a risk ratio of 0.88) out of 2,747 patients in the placebo group.
The first 癀 class 1 new drug approved clinical sword refers to solid tumors
Time of Update: 2020-09-25
the second half of this year, a total of two chemical class 1 new drugs declared clinical, respectively, PZH2109 capsules, PZH2111 tablets.
SLEEP 2020: DAYVIGO (lemborexant) treats adult insomnia, and Phase III clinically confirms its effectiveness and safety
Time of Update: 2020-09-25
Eisai Pharmaceuticals today published the main results of clinical studies in SUNRISE 1 and SUNRISE 2 that analyzed the long-term efficacy and safety of DAYVIGO's treatment of insomniacs aged 65 and over.
The bisceptoin pharmaceutical industry passed a consistent evaluation of the mothamine capsule
Time of Update: 2020-09-20
Company's tymoamine capsule (20mg) was approved for drug registration in December 2011 and is listed as a Class B product in the National Health Insurance Directory.
Ferrero cocoa sauce is alleged to contain excitable toxins and related products are sold in China
Time of Update: 2020-09-05
Some netizens have published articles saying that it contains balsamic, an excitable toxin that stimulates the brain's reward system and makes people feel more delicious than their original taste.
Chongqing paint quality spot check announcement multi-brand 6% of products formaldehyde exceeded the standard
Time of Update: 2020-08-27
Among them, 3 batches of paint were detected free formaldehyde exceeding the standard, is a serious non-conforming products.
Enhua Pharmaceuticals CY150112 tablets and TRV-130 injections were approved clinically
Time of Update: 2020-08-20
Drug-related conditions are as follows: First, CY150112 film clinical trial notice main content Drug name: CY150112 tablets acceptance number: CXHL2000134; CXHL2000135; CXHL2000136 dose type: tablet registration classification: chemical drugs Class